IRCCS Ospedale San Raffaele Milano
Milan 20132
2 studies enrolling now · 6 studies all time
What they study most
Diabetes Mellitus, Early Alzheimer's Disease, Early Alzheimer´s Disease, Metastatic Head-and-neck Squamous-cell Carcinoma, Obesity, Overweight, Recurrent Head and Neck Squamous Cell Carcinoma, Type 2 Diabetes
Studies at this site
- AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight — Recruiting now
- A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma — Recruiting now
- Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide — Running, not enrolling
- A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE) — Completed
- A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) — Completed
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise — Completed